Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06015165Recruiting
Randomised, open-label trial of sufentanil in postoperative pain (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Time of recovery of work and life after surgery day at 21 days. Started Sep 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06015165.